Sacubitril/valsartan vs. valsartan initiation in patients with heart failure and EF>40% who are naive to renin-angiotensin-system inhibitors: Insights from PARAGLIDE-HF
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: Chronic heart failure - treatment 7
Ferric carboxymaltose in heart failure with iron deficiency - the HEART-FID and AFFIRM-AHF trials
Event: Heart Failure 2024
Topic: Anaemia/Iron Deficiency
Session: Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?
HEART-FID: a pragmatic trial in the US
Event: Heart Failure 2024
Topic: Comorbidities
Session: Comorbidities: how to treat, how to define iron deficiency
Ask the Trialist - HEART-FID
Event: ESC Congress 2023
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Ask the Trialists from Hot Line 2
HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency
Event: ESC Congress 2023
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: HOT LINE 2
Interactive panel discussion
Event: Heart Failure 2023
Topic: Chronic Heart Failure
Session: Two decades of research on iron deficiency in heart failure: looking back and moving forward
Moving forward - knowledge gaps and ongoing trials
Event: Heart Failure 2023
Topic: Chronic Heart Failure
Session: Two decades of research on iron deficiency in heart failure: looking back and moving forward
PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Late breaking clinical trials: medical therapy
Fundamentals in iron deficiency and IV iron
Event: Heart Failure 2023
Topic: Chronic Heart Failure
Session: IV iron: the story so far
Clinical outcome predictions for the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial
Event: Heart Failure 2021
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2
